What did small studies find about CJC-1295?
See what happened when people and animals received CJC-1295. You'll also learn why an added link, called DAC, keeps one form in the blood for days.
What is the clearest CJC-1295 finding?
Yes. Small studies found that CJC-1295 can raise growth hormone for days. The drug copies a message from your brain to the growth gland; this small gland sits beneath your brain and sends growth hormone through your bloodstream. Its design uses the first 29 building blocks in that message. Scientists changed four pieces so blood wouldn't break the drug down so fast. The long form has DAC, an added link to albumin. Albumin is one of the proteins carried in your blood. In healthy adults, half the long form took about 5.8-8.1 days to leave [1]. The body's own message is gone within minutes, but one shot also raised insulin-like growth factor, called IGF-1. Your liver makes IGF-1 to help with growth and repair [1].
When you compare the forms, remember that the long stay belongs to DAC.
One study gave healthy adults either 30 or 60 micrograms per kilogram, with body weight setting the total. With the smaller shot, average growth hormone reached 2 times its starting level; the larger shot raised it ten times. Both rises lasted through the sixth day. IGF-1 stayed higher for 9 to 11 days. After more doses, IGF-1 remained above its starting level through 28 days [1]. Another study followed healthy young men for one week. Their daily average rose about 46%, yet their bodies kept releasing growth hormone in the usual bursts [3].
Rat work shows why the DAC form stays longer. Over two hours, the linked drug led to roughly four times the growth hormone seen with the unlinked form. The drug remained in rat blood after 72 hours [2]. CJC-1295 isn't approved as treatment for people, and work on its long form stopped [1].
The studies show you a hormone rise that lasted, not better health.
What body message does CJC-1295 copy?
CJC-1295 copies the body's order to release growth hormone. Four protein pieces were changed, which makes blood break the drug down more slowly. The long form adds DAC, a link to albumin that carries the drug through your blood for days [1][2]. The short form has the four changes but lacks that link, so your blood removes it more quickly [12].
The four changes happen at places scientists number 2, 8, 15, and 27. Blood enzymes are proteins that cut other proteins like scissors [8]. The first change did the most to slow that cutting [7]. DAC then adds the albumin link. Read how the drug reaches the growth gland.
When you compare the forms, the four changes slow breakdown and DAC adds more time in blood.
What happens after CJC-1295 reaches the growth gland?
The drug reaches a receiving place on cells of the growth gland. The cells then release growth hormone stored in the gland. In response, your liver produces insulin-like growth factor, called IGF-1. That hormone helps govern growth and repair. In studies on people, one shot kept both hormones high for days [1][3]. Inside each cell, the drug's message starts the steps that make and release more growth hormone [2].
The gland still sent growth hormone out in natural bursts [3]. The flow didn't turn into one flat stream. The level between bursts rose, and IGF-1 stayed higher. Researchers saw those bursts in healthy adults [1][3].
The level rose, but your body's usual bursts did not disappear. That is the result you can carry forward.
Does “CJC-1295 research peptide” mean approved care?
No. Calling CJC-1295 a research peptide means it is a small drug built from linked protein pieces. It isn't approved care. Labs receive CJC-1295 as a dry powder. They add water that slows germ growth and keep the mixture cold [1]. Your stomach breaks this kind of drug apart, so swallowing gives the body almost none. Most studies put the dose beneath the skin. A much earlier study on the body's short message used a vein [9].
Human CJC-1295 studies are few and cover little time. Other work used rats and mice [1][2][4]. A 2024/2025 review said drugs in this group still need proof that they help people [13]. You can see the study amounts and time in blood for each form.
When you see research peptide, remember that the words don't prove safety or benefit.
Where are the open safety questions?
Read what people say happened and what studies never tested. Personal reports stay apart from study facts there. Start with that page if long-term safety is your main question.